These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1243822)

  • 21. High-resolution chromatography provides the answer to the 15-year-old problem of azaribine toxicity.
    Kovach JS
    J Lab Clin Med; 1977 Nov; 90(5):771-2. PubMed ID: 578520
    [No Abstract]   [Full Text] [Related]  

  • 22. Azaribine, homocystinemia, and thrombosis.
    Shupack JL; Grieco AJ; Epstein AM; Sansaricq C; Snyderman SE
    Arch Dermatol; 1977 Sep; 113(9):1301-2. PubMed ID: 578401
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytostatic therapy of psoriasis].
    Groth O
    Lakartidningen; 1979 Oct; 76(43):3770-1. PubMed ID: 583353
    [No Abstract]   [Full Text] [Related]  

  • 24. When to try antineoplastic agents in psoriasis.
    McDonald CJ
    Med Times; 1977 Aug; 105(8):68-80. PubMed ID: 577996
    [No Abstract]   [Full Text] [Related]  

  • 25. An appraisal of current systemic chemotherapy for psoriasis.
    Farber EM; Pearlman D; Abel EA
    Arch Dermatol; 1976 Nov; 112 Spec no():1679-88. PubMed ID: 793537
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of psoriasis 1975.
    Van Scott EJ
    JAMA; 1976 Jan; 235(2):197-8. PubMed ID: 946030
    [No Abstract]   [Full Text] [Related]  

  • 27. Nucleoside analogs in the treatment of nonneoplastic diseases.
    Calabresi P; Doolittle CH; Heppner GH; McDonald CJ
    Ann N Y Acad Sci; 1975 Aug; 255():190-201. PubMed ID: 1059354
    [No Abstract]   [Full Text] [Related]  

  • 28. Time-response curves in the evaluation of the clinical efficacy of drugs.
    Jankú I; Elis J; Rasková H
    Eur J Clin Pharmacol; 1971 Sep; 3(4):194-7. PubMed ID: 5151302
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppressive agents in the treatment of psoriasis].
    Ruszczak Z
    Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862
    [No Abstract]   [Full Text] [Related]  

  • 30. Psoriasis: clinical aspects and management.
    Rees RB
    Cutis; 1976 Aug; 18(2):231-5. PubMed ID: 828093
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
    Slavik M; Lovenberg W; Keiser HR
    Biochem Pharmacol; 1973 Jun; 22(11):1295-300. PubMed ID: 4727783
    [No Abstract]   [Full Text] [Related]  

  • 32. Psoriasis: a review. II.
    Baker H
    Dermatologica; 1975; 150(3):136-53. PubMed ID: 1098945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous uses of the antiproliferative drugs.
    McDonald CJ
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):934-9. PubMed ID: 4138632
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate.
    Catalanotto FA; Slavik M; Danilson D; Keiser HR; Henkin RI
    Pharmacol Ther Dent; 1975; 2(1):25-32. PubMed ID: 1054856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azaribine-homocystinemia-thrombosis in historical perspective.
    Drell W; Welch AD
    Pharmacol Ther; 1989; 41(1-2):195-206. PubMed ID: 2469090
    [No Abstract]   [Full Text] [Related]  

  • 37. Postmarketing surveillance of new drugs: II. Case studies.
    Wardell WM; Tsianco MC; Anavekar SN; Davis HT
    J Clin Pharmacol; 1979 Apr; 19(4):169-84. PubMed ID: 374427
    [No Abstract]   [Full Text] [Related]  

  • 38. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
    Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
    Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic cyclosporine treatment in severe childhood psoriasis: A retrospective chart review.
    Dogra S; Mahajan R; Narang T; Handa S
    J Dermatolog Treat; 2017 Feb; 28(1):18-20. PubMed ID: 27771982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine as maintenance therapy in patients with severe psoriasis.
    Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.